SciClone Pharmaceuticals (Holdings) Financial Health
How is SciClone Pharmaceuticals (Holdings)'s financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 6600's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥912.9M).
Long Term Liabilities: 6600's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥832.6M).
Debt to Equity History and Analysis
Debt Level: 6600 has more cash than its total debt.
Reducing Debt: 6600's debt to equity ratio has increased from 0% to 46.6% over the past 5 years.
Debt Coverage: 6600's debt is well covered by operating cash flow (103.3%).
Interest Coverage: 6600's interest payments on its debt are well covered by EBIT (53.4x coverage).